Methotrexate Sodium Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Methotrexate Sodium Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Mar 13, 2023.

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-122-50
Dosage Form
Injection
Presentation
Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)
Initial Posting
Mar 13, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.